| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
18.54(B) |
| Last
Volume: |
676,634 |
Avg
Vol: |
1,177,221 |
| 52
Week Range: |
$120.62 - $144.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 724 |
| Guru Rank Value : 1.3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
16,337 |
16,337 |
16,337 |
534,469 |
| Total Sell Value |
$2,062,619 |
$2,062,619 |
$2,062,619 |
$75,079,355 |
| Total People Sold |
3 |
3 |
3 |
6 |
| Total Sell Transactions |
6 |
6 |
6 |
24 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,919 |
10,656 |
|
- |
|
| Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2023-02-23 |
4 |
D |
$147.86 |
$36,226 |
D/D |
(245) |
8,737 |
|
- |
|
| Samad Samer Abdul |
Executive Vice President & CFO |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,710 |
20,384 |
|
- |
|
| Rusckowski Stephen H |
Director |
– • – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,059 |
349,066 |
|
- |
|
| Rusckowski Stephen H |
Director |
– • – |
2023-02-23 |
4 |
D |
$147.86 |
$861,432 |
D/D |
(5,826) |
329,007 |
|
- |
|
| Deppe Michael J |
SVP, Corp. Controller & CAO |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
498 |
32,328 |
|
- |
|
| Deppe Michael J |
SVP, Corp. Controller & CAO |
• – – |
2023-02-23 |
4 |
D |
$147.86 |
$27,798 |
D/D |
(188) |
31,825 |
|
- |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,838 |
70,609 |
|
- |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2023-02-23 |
4 |
D |
$147.86 |
$142,241 |
D/D |
(962) |
66,771 |
|
- |
|
| Davis J. E. |
CEO and President |
• • – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
17,443 |
96,758 |
|
- |
|
| Davis J. E. |
CEO and President |
• • – |
2023-02-23 |
4 |
D |
$147.86 |
$217,798 |
D/D |
(1,473) |
79,315 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,094 |
9,904 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2023-02-23 |
4 |
D |
$147.86 |
$28,833 |
D/D |
(195) |
7,810 |
|
- |
|
| Gardner Mark A |
SVP of Molecular Gen & Oncol |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,919 |
2,921 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,442 |
40,855 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2023-02-23 |
4 |
D |
$147.86 |
$119,914 |
D/D |
(811) |
38,413 |
|
- |
|
| Gregg Vicky B |
Director |
– • – |
2023-02-01 |
4 |
A |
$146.75 |
$9,392 |
D/D |
64 |
17,130 |
|
- |
|
| Plewman Patrick |
SVP for Diagnostic Services |
• – – |
2023-02-01 |
4 |
A |
$146.75 |
$3,962 |
D/D |
27 |
8,982 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical Solutions |
• – – |
2023-02-01 |
4 |
A |
$146.75 |
$1,908 |
D/D |
13 |
8,005 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2022-12-01 |
4 |
AS |
$152.50 |
$308,813 |
D/D |
(2,025) |
24,149 |
|
-7% |
|
| Ring Timothy M |
Director |
– • – |
2022-12-01 |
4 |
OE |
$53.13 |
$116,214 |
D/D |
2,025 |
26,174 |
|
- |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2022-11-28 |
4 |
AS |
$148.92 |
$6,081,262 |
D/D |
(40,765) |
67,733 |
|
-4% |
|
| Doherty Catherine T. |
SVP, Regional Businesses |
• – – |
2022-11-28 |
4 |
OE |
$86.63 |
$3,531,472 |
D/D |
40,765 |
108,498 |
|
- |
|
| Kuppusamy Karthik |
SVP, Clinical SolutionsOfficer |
• – – |
2022-11-16 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,754 |
|
- |
|
| Gardner Mark A |
SVP of Molecular Gen & OncolOf |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,002 |
|
-7% |
|
787 Records found
|
|
Page 5 of 32 |
|
|
0.63 (0.46%) 
